Results 121 to 130 of about 11,904 (210)

Effects of hydromethylthionine mesylate and rivastigmine in a pharmacological mouse model of Alzheimer's disease. [PDF]

Behav Pharmacol
Robinson L, Bray J, Melis V, Harrington CR, Wischik CM, Riedel G.   +5 more
europepmc   +1 more source

Switching from Oral Cholinesterase Inhibitors to a Transdermal Donepezil Patch Attenuated Gastrointestinal Symptoms and Allowed Treatment Continuation in Three Patients with Alzheimer's Disease in Clinical Settings. [PDF]

Brain Sci
Motoi Y, Sanjo N.
europepmc   +1 more source

Dynamic associations of cholinesterase inhibitors and memantine with cognitive trajectories in individuals with Alzheimer's or mixed dementia: a real-world analysis using the quality registry SveDem. [PDF]

Alzheimers Res Ther
Chen C, Mo M, Åkerman M, Garcia-Ptacek S, Xu H, Eriksdotter M.   +5 more
europepmc   +1 more source

Disease stage in Alzheimer disease and treatment effects of rivastigmine.

, 2004
The efficacy and tolerability of the cholinesterase inhibitor rivastigmine in the treatment of Alzheimer disease (AD) have been demonstrated in several clinical trials, which included patients with a wide range of dementia severities.
Kurz, A;Farlow, M;Quarg, P;Spiegel, R
core  

Retraction: Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Prescription cascades associated with acetylcholinesterase inhibitors use: a high-throughput sequence symmetry analysis. [PDF]

Age Ageing
Newby D, Bobba SS, Raventós B, Rowlands EJ, Chen X, Molina-Porcel L, Reyes C, Duarte-Salles T, Delmestri A, Man WY, Burn E, Catala Sabate M, Pratt N, Jödicke AM, Prieto-Alhambra D.   +14 more
europepmc   +1 more source

Design and synthesis of new phosphazine and triazole derivatives for treatment of Alzheimer's disease: modulating ROS/JNK and Wnt/β-catenin signaling pathways. [PDF]

RSC Adv
Salah RS, El-Sayed NF, El-Hussieny M, Mansour ST, Othman M, Fouad MA, Rashdan HRM, Ewies EF, Gharib HSA, Elsayed GH.   +9 more
europepmc   +1 more source

Pharmacokinetics of Double-Layer Patches With Microneedles Containing Procyclidine and Rivastigmine in Guinea Pigs. [PDF]

Basic Clin Pharmacol Toxicol
Moon M, Won J, Lee YW, Jeon S, Yoon Y, Jeong JH, Kang W.   +6 more
europepmc   +1 more source

Dementia data for people living in care homes: cross-sectoral national data linkage study of care home, healthcare and administrative data sources. [PDF]

Int J Popul Data Sci
Mavromati K, Drelciuc M, Lynch E, Hay SA, Hanlon P, Quinn TJ, Burton JK.   +6 more
europepmc   +1 more source

Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]

J Alzheimers Dis
Heo RJ, Negida A, Barrett MJ, Chrenka EA, Bayram E, Kane JPM, Werner AM, Rossom RC, Wyman-Chick KA.   +8 more
europepmc   +1 more source